Prosper N. Boyaka

4.9k total citations
98 papers, 3.6k citations indexed

About

Prosper N. Boyaka is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Prosper N. Boyaka has authored 98 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 25 papers in Molecular Biology and 17 papers in Infectious Diseases. Recurrent topics in Prosper N. Boyaka's work include Immune Cell Function and Interaction (18 papers), Immune Response and Inflammation (18 papers) and T-cell and B-cell Immunology (15 papers). Prosper N. Boyaka is often cited by papers focused on Immune Cell Function and Interaction (18 papers), Immune Response and Inflammation (18 papers) and T-cell and B-cell Immunology (15 papers). Prosper N. Boyaka collaborates with scholars based in United States, Japan and France. Prosper N. Boyaka's co-authors include Jerry R. McGhee, James W. Lillard, Estelle Cormet‐Boyaka, Kohtaro Fujihashi, Mariarosaria Marinaro, Romy Fischer, Raymond J. Jackson, Hiroshi Kiyono, M. Dubarry and Joost J. Oppenheim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Prosper N. Boyaka

98 papers receiving 3.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Prosper N. Boyaka 1.5k 934 679 549 417 98 3.6k
Kol A. Zarember 2.3k 1.5× 1.0k 1.1× 677 1.0× 737 1.3× 355 0.9× 40 3.8k
Catherine Werts 2.3k 1.6× 1.4k 1.5× 944 1.4× 550 1.0× 194 0.5× 70 4.8k
Marie‐Louise Hammarström 1.8k 1.2× 1.2k 1.3× 284 0.4× 773 1.4× 164 0.4× 96 4.4k
Marie‐Anne Nahori 1.4k 0.9× 1.6k 1.8× 602 0.9× 607 1.1× 280 0.7× 60 4.7k
Stefano Censini 3.3k 2.2× 930 1.0× 505 0.7× 849 1.5× 525 1.3× 61 6.4k
Dane Parker 1.2k 0.8× 1.3k 1.4× 1.2k 1.8× 729 1.3× 363 0.9× 76 3.8k
Tomonori Nochi 2.1k 1.4× 1.6k 1.7× 972 1.4× 541 1.0× 150 0.4× 102 4.9k
Mona Bajaj‐Elliott 1.3k 0.9× 984 1.1× 714 1.1× 477 0.9× 125 0.3× 89 3.6k
Lutz Hamann 1.8k 1.2× 626 0.7× 627 0.9× 778 1.4× 213 0.5× 62 3.2k
Masahito Hashimoto 2.5k 1.7× 1.3k 1.3× 564 0.8× 688 1.3× 210 0.5× 64 4.1k

Countries citing papers authored by Prosper N. Boyaka

Since Specialization
Citations

This map shows the geographic impact of Prosper N. Boyaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prosper N. Boyaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prosper N. Boyaka more than expected).

Fields of papers citing papers by Prosper N. Boyaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prosper N. Boyaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prosper N. Boyaka. The network helps show where Prosper N. Boyaka may publish in the future.

Co-authorship network of co-authors of Prosper N. Boyaka

This figure shows the co-authorship network connecting the top 25 collaborators of Prosper N. Boyaka. A scholar is included among the top collaborators of Prosper N. Boyaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prosper N. Boyaka. Prosper N. Boyaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Mijia, Yuexiu Zhang, Chengjin Ye, et al.. (2022). SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern. Proceedings of the National Academy of Sciences. 119(35). e2110105119–e2110105119. 32 indexed citations
2.
Habing, Gregory, et al.. (2022). Effects of Intravenous Antimicrobial Drugs on the Equine Fecal Microbiome. Animals. 12(8). 1013–1013. 14 indexed citations
3.
Rayner, Rachael E., Sheng‐Wei Chang, Sun Hee Kim, et al.. (2022). Targeting the EGFR‐ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del. The FASEB Journal. 36(5). e22270–e22270. 10 indexed citations
4.
Kim, Eunsoo, Hannah Yu, Alice Baek, et al.. (2022). Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage. Biomedicines. 10(6). 1221–1221. 1 indexed citations
5.
Kim, Eunsoo, Cong Zeng, Sun Hee Kim, et al.. (2021). Inhibition of elastase enhances the adjuvanticity of alum and promotes anti–SARS-CoV-2 systemic and mucosal immunity. Proceedings of the National Academy of Sciences. 118(34). 20 indexed citations
6.
Xue, Miaoge, Yuexiu Zhang, Haitao Wang, et al.. (2021). Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus. PLoS Pathogens. 17(12). e1010142–e1010142. 27 indexed citations
7.
8.
Vadia, Stephen, Prosper N. Boyaka, Sanjay Varikuti, et al.. (2020). A listeriolysin O subunit vaccine is protective against Listeria monocytogenes. Vaccine. 38(36). 5803–5813. 17 indexed citations
9.
10.
Yasmeen, Rumana, Carlos E. Alvarez, Hansjüerg Alder, et al.. (2013). Aldehyde dehydrogenase-1a1 induces oncogene suppressor genes in B cell populations. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 3218–3227. 11 indexed citations
11.
12.
Duverger, Alexandra, Raymond J. Jackson, Romy Fischer, et al.. (2006). Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens. The Journal of Immunology. 176(3). 1776–1783. 53 indexed citations
13.
Hagiwara, Yukari, Yuki I. Kawamura, Kosuke Kataoka, et al.. (2006). A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking. The Journal of Immunology. 177(5). 3045–3054. 33 indexed citations
14.
Fischer, Romy, Jerry R. McGhee, Huong Vu, et al.. (2005). Oral and Nasal Sensitization Promote Distinct Immune Responses and Lung Reactivity in a Mouse Model of Peanut Allergy. American Journal Of Pathology. 167(6). 1621–1630. 44 indexed citations
15.
Boyaka, Prosper N., Angela Tafaro, Romy Fischer, et al.. (2003). Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen. The Journal of Immunology. 170(11). 5636–5643. 113 indexed citations
16.
Boyaka, Prosper N., Mari Ohmura, Kohtaro Fujihashi, et al.. (2003). Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit. The Journal of Immunology. 170(1). 454–462. 44 indexed citations
17.
Boyaka, Prosper N., et al.. (2003). The [173–196] fragment of ovalbumin suppresses ovalbumin-specific rat IgE responses. International Immunopharmacology. 3(12). 1569–1579. 5 indexed citations
18.
Boyaka, Prosper N., Mariarosaria Marinaro, Raymond J. Jackson, et al.. (2001). Oral QS-21 Requires Early IL-4 Help for Induction of Mucosal and Systemic Immunity. The Journal of Immunology. 166(4). 2283–2290. 46 indexed citations
19.
Boyaka, Prosper N., Mariarosaria Marinaro, John L. VanCott, et al.. (1999). Strategies for mucosal vaccine development.. American Journal of Tropical Medicine and Hygiene. 60(4_suppl). 35–45. 35 indexed citations
20.
Kawabata, Shigetada, Prosper N. Boyaka, Kohtaro Fujihashi, et al.. (1998). Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics. Gastroenterology. 115(4). 866–873. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kol A. Zarember Breakdown of academic impact, for papers by Catherine Werts Breakdown of academic impact, for papers by Marie‐Louise Hammarström Breakdown of academic impact, for papers by Marie‐Anne Nahori Breakdown of academic impact, for papers by Stefano Censini Breakdown of academic impact, for papers by Dane Parker Breakdown of academic impact, for papers by Tomonori Nochi Breakdown of academic impact, for papers by Mona Bajaj‐Elliott Breakdown of academic impact, for papers by Lutz Hamann Breakdown of academic impact, for papers by Masahito Hashimoto
Rankless by CCL
2026